Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Serum and synovial lactate dehydrogenase levels after allogeneic mesenchymal stem cell implantation in rabbit cartilage defects.

Anatolitou A., Mavrogenis AF., Sideri KI., Psalla D., Markou M., Prassinos NN.

Animal Study on Cartilage Damage, published in Pol J Vet Sci (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Pol J Vet Sci (2026)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
42299097
DOI
10.24425/pjvs.2026.1266

Abstract (original English)

Cartilage defects have limited regenerative potential and remain a significant clinical challenge. Mesenchymal stem cell (MSC) therapy offers promise in tissue engineering, yet monitoringpost-implantation responses remains difficult. Lactate dehydrogenase (LDH), a biomarkerof cell damage and inflammation, may provide insight into systemic and local tissue reactions. This study aimed to assess the levels of serum and synovial fluid LDH following the implantation of allogeneic MSCs into cartilage defects in a rabbit model. A total of 56 New Zealand white rabbits were randomly divided into four groups: control (Group A), and groups receiving fibrin glue with adipose-derived stem cells (ASCs), bone marrow-derived stem cells (BMSCs), or synovial-derived stem cells (SDSCs). Serum and synovial fluid samples were collected at baseline and 12 weeks post-surgery to measure serum and synovial fluid LDH levels. Serum LDH levels were significantly elevated in all MSC-treated groups relative to controls (p=0.019), potentially due to high anaerobic metabolism or implantation-related toxicity, systemic response and apoptosis. However, no additional adverse effects were observed, making toxicity or further articular damage unlikely. No significant changes were detected in synovial fluid LDH across groups (p=0.070), suggesting limited value as a biomarker for cartilage repair.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsRabbitsSynovial FluidMesenchymal Stem Cell TransplantationL-Lactate DehydrogenaseMesenchymal Stem CellsTransplantation, HomologousCartilage

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research